Medical Cannabis Evidence-Based Care: Phase 3 Trial Results
This phase 3 cannabis trial chronic low back pain study evaluated the full-spectrum cannabis extract VER-01 in 820 adults. The trial demonstrated significant pain reduction over 12 weeks with sustained effects. These results provide important evidence…
Endocannabinoid System & Chronic Pain: Clinical Evidence Review
Clinical trials demonstrate cannabinoids for chronic pain clinical evidence with modest reductions in neuropathic and mixed pain. Benefits are often accompanied by adverse effects like dizziness and sedation. Patients and clinicians should weigh these…
Endocannabinoid System Research: Cannabis for Chronic Pain
The cannabinoids chronic pain evidence review 2025 highlights measurable but modest pain relief for chronic pain conditions. Effects vary based on THC-to-CBD ratio, cannabinoid source, and delivery method. Clinicians should weigh benefits against harms…
Study Finds Cannabis Use, Anxiety, and Depression Rising in Canada
A Canadian study highlights cannabis use anxiety treatment evidence by showing rising rates of cannabis use alongside anxiety and depression. The research reveals a consistent association between cannabis use and mood disorders. This evidence underscores…
